BRTH Share Price Performance
US$0
0.00 (0.00%)
Sorry, there is currently no price data for this company.
BRTH Community Narratives
There are no narratives available yet.
Recent BRTH News & Updates
No updates
Breathe BioMedical Inc. Key Details
Last Reported Earnings
Mar 31, 2024
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.97
- Gross Margin
- 0%
- Net Profit Margin
- 0%
- Debt/Equity Ratio
- 1,548.4%
Breathe BioMedical Inc. Competitors
Snowflake Analysis
About BRTH
- Founded
- 2005
- Employees
- 26
- CEO
- WebsiteView website
Breathe BioMedical Inc., a development-stage medical technology company, focuses on developing a breath test to detect early-stage breast cancer in women. Its test consists of SohnoXB Breath Sampler, a tabletop device that is used to collect alveolar breath from patients; a breath collection kit to store the breath sample during transportation to its laboratory facilities; a spectrometer to process breath samples; and a machine learning algorithm to analyze the breath spectral data from the spectrometer. Breathe BioMedical Inc. was formerly known as Picomole Inc. and changed its name to Breathe BioMedical Inc. in November 2023. The company was incorporated in 2005 and is based in Moncton, Canada.
Market Insight
The number of IPOs and the capital raised this year are on track to outpace the last three years combined. And the thing is, successful IPOs attract more IPOs. Some will be genuine gems, while others, not so much. That’s why this week, we’re digging into the IPO market, and more importantly, how you can improve your odds of spotting a winner.
Continue reading
Canadian Market Performance
- 7 Days: 1.4%
- 3 Months: 7.6%
- 1 Year: 19.5%
- Year to Date: 13.4%
Over the last 7 days, the market has risen 1.4%, driven by gains of 2.2% in the Financials sector. In contrast, the Consumer Staples sector is lagging, dropping 3.6%. The market is up 20% over the last 12 months. Looking forward, earnings are forecast to grow by 11% annually. Market details ›